Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1140 | DWJ1248 Wiki | 1.00 |
| drug2916 | Placebo Wiki | 0.04 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D000071069 | Multiple Chronic Conditions NIH | 1.00 |
| D002908 | Chronic Disease NIH | 0.27 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this study is to ensure effective health management among community-living older adults during unprecedented times, such as the current COVID-19 pandemic.
Description: Health Education Impact Questionnaire (HeiQ) that evaluates health directed behaviour for chronic disease management.
Measure: Change from baseline: Health Directed Behaviour at 2 months Time: Baseline, Post-intervention (immediately after the 2-month intervention)Description: 21-item survey scale that looks at perceived depression, anxiety and stress.
Measure: Depression, Anxiety, Stress Scale Time: Baseline, Post-intervention (immediately after the 2-month intervention)Description: 19-item survey that evaluates perceived social support.
Measure: Medical Outcomes Study (MOS): Social Support Survey Time: Baseline, Post-intervention (immediately after the 2-month session)Description: Survey scale that evaluates at health-related quality of life.
Measure: Medical Outcomes Study (MOS): Short Form-36 Time: Baseline, Post-intervention (immediately after the 2-month session)Description: 28-item survey scale that looks at health promotion self-efficacy.
Measure: Self-Rated Abilities for Health Practices Scale Time: Baseline, Post-intervention (immediately after the 2-month session)Description: Health Education Impact Questionnaire
Measure: Self-management Time: Baseline, Post-intervention (immediately after the 2-month session)Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports